Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRVS

Corvus Pharmaceuticals Inc

May 05 • 04:00PM ET

15.70

-0.32 -2.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BMY GILD REGN VRTX INCY EXEL BLUE IONS BMRN SRPT

| Held by: XBI VTI IWM VXF IWO IBB VTWO IWC VHT VFMO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	23.76%	Shs Outstand	74.70M	Perf Week	0.51%
Market Cap	1.32B	Forward P/E	-	EPS next Y	-0.72	Insider Trans	0.00%	Shs Float	64.11M	Perf Month	6.73%
Enterprise Value	1.26B	PEG	-	EPS next Q	-0.14	Inst Own	36.87%	Short Float	26.40%	Perf Quarter	-26.43%
Income	-15.28M	P/S	-	EPS this Y	-233.16%	Inst Trans	6.11%	Short Ratio	12.94	Perf Half Y	95.27%
Sales	0.00M	P/B	19.16	EPS next Y	-13.22%	ROA	-21.83%	Short Interest	16.93M	Perf YTD	103.90%
Book/sh	0.82	P/C	23.26	EPS next 5Y	-	ROE	-32.60%	52W High	26.95 -41.74%	Perf Year	340.39%
Cash/sh	0.67	P/FCF	-	EPS past 3/5Y	15.40% -21.44%	ROIC	-24.75%	52W Low	3.16 396.05%	Perf 3Y	1208.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.96% 7.18%	Perf 5Y	447.04%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	83.13%	Oper. Margin	-	ATR (14)	1.17	Perf 10Y	26.41%
Dividend Ex-Date	-	Quick Ratio	6.21	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.78	Recom	1.14
Dividend Gr. 3/5Y	- -	Current Ratio	6.21	EPS Q/Q	16.20%	SMA20	0.03%	Beta	0.93	Target Price	33.33
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	0.57%	Rel Volume	0.59	Prev Close	16.02
Employees	37	LT Debt/Eq	0.01	Earnings	Mar 12 AMC	SMA200	47.81%	Avg Volume	1.31M	Price	15.70
IPO	Mar 23, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.92% -	Trades		Volume	772,667	Change	-2.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)